Lactation Suppressed
7
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
A Reduced Dose of Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss
Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss
Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion
Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss
Lactation Inhibition, the Efficiency of Vitamin B6 Versus Cabergoline
Factors and Outcomes Associated With Postpartum Cabergoline Use
Satisfaction of Patients With the Chosen Method of Inhibition of Lactation